Progyny, Inc. (PGNY)
NASDAQ: PGNY · IEX Real-Time Price · USD
31.72
-0.35 (-1.09%)
At close: May 3, 2024, 4:00 PM
32.00
+0.28 (0.88%)
After-hours: May 3, 2024, 6:44 PM EDT
Progyny Revenue
In the year 2023, Progyny had annual revenue of $1.09B with 38.34% growth. Revenue in the quarter ending December 31, 2023 was $269.94M with 25.95% year-over-year growth.
Revenue (ttm)
$1.09B
Revenue Growth
+38.34%
P/S Ratio
2.81
Revenue / Employee
$1,923,318
Employees
566
Market Cap
3.06B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.09B | 301.69M | 38.34% |
Dec 31, 2022 | 786.91M | 286.29M | 57.19% |
Dec 31, 2021 | 500.62M | 155.76M | 45.17% |
Dec 31, 2020 | 344.86M | 115.18M | 50.15% |
Dec 31, 2019 | 229.68M | 124.28M | 117.92% |
Dec 31, 2018 | 105.40M | 56.82M | 116.94% |
Dec 31, 2017 | 48.58M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Surgery Partners | 2.74B |
Amedisys | 2.25B |
Evolent Health | 1.96B |
Sotera Health Company | 1.05B |
10x Genomics | 625.45M |
Amicus Therapeutics | 399.36M |
Immunocore Holdings | 249.43M |
Arrowhead Pharmaceuticals | 181.74M |
PGNY News
- 8 days ago - Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report - GlobeNewsWire
- 16 days ago - Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care - GlobeNewsWire
- 4 weeks ago - Jim Cramer recommends five small-cap health-care stocks - CNBC
- 4 weeks ago - Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast - GlobeNewsWire
- 6 weeks ago - Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum - GlobeNewsWire
- 7 weeks ago - This overlooked corner of women's health could be a $350 billion market opportunity - CNBC
- 7 weeks ago - Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Progyny, Inc. Announces Share Repurchase Program - GlobeNewsWire